Related Experiment Video
Updated: Dec 13, 2025

Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
Published on: May 16, 2019
Association of Zinc and Copper Status with Cardiovascular Diseases and their Assessment Methods: A Review Study
Mahsa Malekahmadi1, Safieh Firouzi1, Majid Rezayi2
1Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Insights
Zinc and copper deficiencies may increase cardiovascular disease (CVD) risk, impacting heart health and inflammation. Accurate assessment methods are crucial but require further research for CVD correlation.
Area of Science:
- Nutritional Biochemistry
- Cardiovascular Medicine
- Mineral Metabolism
Background:
- Cardiovascular disease (CVD) is a global health crisis, causing significant mortality and economic burden.
- Essential minerals zinc and copper play vital roles in human health, with their status linked to various CVD types.
- Existing research on the association between zinc/copper status and CVD presents conflicting findings.
Purpose of the Study:
- To review the correlation between human zinc and copper status and CVD risk factors.
- To survey the methods used for assessing zinc and copper status.
- To synthesize current knowledge on mineral status and cardiovascular health.
Main Methods:
- Narrative review of existing scientific literature.
- Analysis of studies investigating zinc and copper levels in relation to CVD.
- Evaluation of direct and indirect methods for mineral status assessment.
Main Results:
- Zinc and copper deficiency are associated with increased risk of coronary heart disease, valvular regurgitation, myocardial lesions, and cardiac hypertrophy.
- Deficiencies may lead to cardiac mitochondrial expansion, heart failure, and elevated inflammation markers (IL-1, IL-6).
- Direct and indirect methods, along with serum/plasma levels, are used for assessment, but their accuracy for CVD correlation needs clarification.
Conclusions:
- Zinc and copper status are significantly implicated in cardiovascular health.
- Further research is essential to determine the most accurate methods for assessing zinc and copper status in the context of CVD.
- Understanding these mineral-CVD links can inform preventative strategies and treatments.
Abstract:
Cardiovascular disease (CVD) is the leading cause of mortality, morbidity, and financial losses and has a high prevalence across the world. Several studies have investigated the association between various CVD types with zinc and copper status as the essential minerals for the human body, proposing contradictory and similar results. This narrative review aimed to survey the correlations between zinc and copper status in the human body and some risk factors of CVD, as well as the assessment methods of zinc and copper status in the human body. According to the reviewed articles, zinc and copper deficiency may increase the risk of coronary heart disease, valvular regurgitation, and myocardial lesions, cardiac hypertrophy. Furthermore, it could lead to the expanded mitochondrial compartments of the heart, acute and chronic heart failure, and elevation of inflammation markers, such as interleukin-1 (IL-1) and IL-6. Two methods are primarily used for the assessment of zinc and copper in the human body, including the direct method (measurement of their concentrations) and indirect method (determining the activity of zinc- and copper-containing enzymes). Both these methods are considered reliable for the assessment of the zinc and copper levels in healthy individuals. Serum or plasma levels of these elements are also commonly used for the assessment of the correlation between zinc and copper status and CVD. But, which one is a more accurate indicator in relation to CVD is not yet clear; therefore, further studies are required in this field.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
06:52Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Related Concept Videos
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT